Strata Skin Scien (SSKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,947 | -14,145 | -25,948 | -22,673 | -20,385 |
| Depreciation Amortization | 12,921 | 3,924 | 2,689 | 970 | 3,746 |
| Income taxes - deferred | 119 | N/A | N/A | N/A | N/A |
| Accounts receivable | -186 | -215 | 77 | -180 | 0 |
| Other Working Capital | -360 | -918 | -157 | 929 | -991 |
| Other Operating Activity | 5,883 | -6,355 | 3,926 | 1,730 | 172 |
| Operating Cash Flow | $-6,570 | $-17,709 | $-19,413 | $-19,224 | $-17,458 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | 17 | -5,188 | -6,158 | -104 |
| Net Acquisitions | -42,500 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,704 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-44,239 | $17 | $-5,188 | $-6,158 | $-104 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 53,000 | 15,000 | 6,000 | N/A | N/A |
| Debt Repayment | -10,103 | N/A | -6,670 | 0 | N/A |
| Common Stock Issued | N/A | 11,458 | 21,192 | 5,247 | 15,038 |
| Other Financing Activity | -227 | -1,115 | 0 | 0 | 0 |
| Financing Cash Flow | $42,670 | $25,343 | $20,522 | $5,247 | $15,038 |
| Exchange Rate Effect | 8 | 0 | N/A | N/A | N/A |
| Beginning Cash Position | 11,434 | 3,783 | 7,862 | 27,997 | 30,521 |
| End Cash Position | 3,303 | 11,434 | 3,783 | 7,862 | 27,997 |
| Net Cash Flow | $-8,131 | $7,651 | $-4,079 | $-20,135 | $-2,524 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,570 | -17,709 | -19,413 | -19,224 | -17,458 |
| Capital Expenditure | N/A | 17 | -5,188 | -6,158 | -104 |
| Free Cash Flow | -6,570 | -17,692 | -24,601 | -25,382 | -17,562 |